Sunshine Heart (SSH) gains on a late-day coverage initiation by Oppenheimer with an...

Sunshine Heart (SSH) gains on a late-day coverage initiation by Oppenheimer with an Outperformrating and a price target of $11. Shares +3.7% AH.

Comments (1)
  • jvcguest
    , contributor
    Comments (30) | Send Message
    I was first enthused about this company years ago when it had recently been floated on the Australian Stock Exchange. The only serious drawback I could forsee was the need to persuade patients and their cardiologists that having a sternotomy performed to put the C-Pulse device in would be hard going. Happily that problem has been long solved. Now I wait in frustration to see at least the beginnings of wider understanding of this company (which has excellent management judging from my contact with them and others who know them) because its present price makes it sitting prey for a billion or multi-billion dollar company to take it over for comparative chickenfeed. I wouldn't sell willingly for under $40 a share this year but there may be others farsighted enough to have bought in early but getting impatient. Still, it will be fascinating to see who rushes in with what bids when more implanations under the European CE mark and many more of the 194 planned for the North American trial are reported, presumably later this year.
    11 Jul 2013, 12:10 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs